214 related articles for article (PubMed ID: 11731354)
1. Efficacy of usual antidepressant dosing regimens of fluoxetine in panic disorder: randomised, placebo-controlled trial.
Michelson D; Allgulander C; Dantendorfer K; Knezevic A; Maierhofer D; Micev V; Paunovic VR; Timotijevic I; Sarkar N; Skoglund L; Pemberton SC
Br J Psychiatry; 2001 Dec; 179():514-8. PubMed ID: 11731354
[TBL] [Abstract][Full Text] [Related]
2. Intravenous administration of adenosine triphosphate and phosphocreatine combined with fluoxetine in major depressive disorder: protocol for a randomized, double-blind, placebo-controlled pilot study.
Chen Y; Cao X; Zang W; Tan S; Ou CQ; Shen X; Gao T; Zhao L
Trials; 2019 Jan; 20(1):34. PubMed ID: 30626424
[TBL] [Abstract][Full Text] [Related]
3. Do antidepressants selectively suppress spontaneous (unexpected) panic attacks? A replication.
Uhlenhuth EH; Matuzas W; Warner TD; Paine S; Lydiard RB; Pollack MH
J Clin Psychopharmacol; 2000 Dec; 20(6):622-7. PubMed ID: 11106133
[TBL] [Abstract][Full Text] [Related]
4. Once-weekly dosing of fluoxetine in the maintenance of remission in panic disorder.
Emmanuel NP; Ware MR; Brawman-Mintzer O; Ballenger JC; Lydiard RB
J Clin Psychiatry; 1999 May; 60(5):299-301. PubMed ID: 10362436
[TBL] [Abstract][Full Text] [Related]
5. Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment.
Pérez V; Gilaberte I; Faries D; Alvarez E; Artigas F
Lancet; 1997 May; 349(9065):1594-7. PubMed ID: 9174562
[TBL] [Abstract][Full Text] [Related]
6. Switching patients from daily citalopram, paroxetine, or sertraline to once-weekly fluoxetine in the maintenance of response for depression.
Miner CM; Brown EB; Gonzales JS; Munir R
J Clin Psychiatry; 2002 Mar; 63(3):232-40. PubMed ID: 11926723
[TBL] [Abstract][Full Text] [Related]
7. The treatment of comorbid premature ejaculation and panic disorder with fluoxetine.
Kindler S; Dolberg OT; Cohen H; Hirschmann S; Kotler M
Clin Neuropharmacol; 1997 Oct; 20(5):466-71. PubMed ID: 9331524
[TBL] [Abstract][Full Text] [Related]
8. Continuing treatment of panic disorder after acute response: randomised, placebo-controlled trial with fluoxetine. The Fluoxetine Panic Disorder Study Group.
Michelson D; Pollack M; Lydiard RB; Tamura R; Tepner R; Tollefson G
Br J Psychiatry; 1999 Mar; 174():213-8. PubMed ID: 10448445
[TBL] [Abstract][Full Text] [Related]
9. Mirtazapine versus fluoxetine in the treatment of panic disorder.
Ribeiro L; Busnello JV; Kauer-Sant'Anna M; Madruga M; Quevedo J; Busnello EA; Kapczinski F
Braz J Med Biol Res; 2001 Oct; 34(10):1303-7. PubMed ID: 11593305
[TBL] [Abstract][Full Text] [Related]
10. Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder.
Ballenger JC; Wheadon DE; Steiner M; Bushnell W; Gergel IP
Am J Psychiatry; 1998 Jan; 155(1):36-42. PubMed ID: 9433336
[TBL] [Abstract][Full Text] [Related]
11. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
Pollack MH; Lepola U; Koponen H; Simon NM; Worthington JJ; Emilien G; Tzanis E; Salinas E; Whitaker T; Gao B
Depress Anxiety; 2007; 24(1):1-14. PubMed ID: 16894619
[TBL] [Abstract][Full Text] [Related]
12. Moclobemide and fluoxetine for panic disorder. International Panic Disorder Study Group.
Tiller JW; Bouwer C; Behnke K
Eur Arch Psychiatry Clin Neurosci; 1999; 249 Suppl 1():S7-10. PubMed ID: 10361960
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of weekly treatment with enteric-coated fluoxetine in patients with major depressive disorder.
Dinan TG
J Clin Psychiatry; 2001; 62 Suppl 22():48-52. PubMed ID: 11599649
[TBL] [Abstract][Full Text] [Related]
14. Venlafaxine extended-release: a review of its use in the management of major depression.
Wellington K; Perry CM
CNS Drugs; 2001; 15(8):643-69. PubMed ID: 11524036
[TBL] [Abstract][Full Text] [Related]
15. Sertraline in the treatment of panic disorder: a flexible-dose multicenter trial.
Pollack MH; Otto MW; Worthington JJ; Manfro GG; Wolkow R
Arch Gen Psychiatry; 1998 Nov; 55(11):1010-6. PubMed ID: 9819070
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of adding fluoxetine to the treatment regimen of hospitalized patients with non-critical COVID-19 pneumonia: A double-blind randomized, placebo-controlled clinical trial.
Sedighi F; Zarghami M; Alizadeh Arimi F; Moosazadeh M; Ala S; Ghasemian R; Mehravaran H; Elyasi F
Neuropsychopharmacol Rep; 2023 Jun; 43(2):202-212. PubMed ID: 36941089
[TBL] [Abstract][Full Text] [Related]
17. Use of low-dose fluoxetine in major depression and panic disorder.
Louie AK; Lewis TB; Lannon RA
J Clin Psychiatry; 1993 Nov; 54(11):435-8. PubMed ID: 8270588
[TBL] [Abstract][Full Text] [Related]
18. Outcome assessment and clinical improvement in panic disorder: evidence from a randomized controlled trial of fluoxetine and placebo. The Fluoxetine Panic Disorder Study Group.
Michelson D; Lydiard RB; Pollack MH; Tamura RN; Hoog SL; Tepner R; Demitrack MA; Tollefson GD
Am J Psychiatry; 1998 Nov; 155(11):1570-7. PubMed ID: 9812120
[TBL] [Abstract][Full Text] [Related]
19. The feasibility of a randomised, placebo-controlled clinical trial of homeopathic treatment of depression in general practice.
Katz T; Fisher P; Katz A; Davidson J; Feder G
Homeopathy; 2005 Jul; 94(3):145-52. PubMed ID: 16060200
[TBL] [Abstract][Full Text] [Related]
20. Venlafaxine extended-release capsules in panic disorder: flexible-dose, double-blind, placebo-controlled study.
Bradwejn J; Ahokas A; Stein DJ; Salinas E; Emilien G; Whitaker T
Br J Psychiatry; 2005 Oct; 187():352-9. PubMed ID: 16199795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
